Active Cancer
Targeted Drug Delivery in EGFR-positive Lung Cancer via Protein Nanoparticles and Artificial Intelligence
About this grant
This summary is based on the grant title only — the full abstract was not available.
No substantive source abstract was published for this research project funded by InnovateUK.
View the original record at the funder ↗
Related Research
Grants with similar aims, by meaning.
Targeting resistance in cancer with double imprinted polymers as drug delivery nano vehicles
Covalent EGFR inhibitors treating drug resistant lung cancer
Nanoparticle imaging method for drug discovery and cancer therapy in humans
Decision support system for recommending EGFR-inhibiting drugs
A Phase 1/2 Study Targeting Acquired Resistance Mechanisms in Patients with EGFR Mutant Non-Small Cell Lung Cancer
Original classification
Feasibility StudiesPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know